SOURCE: Sunwin International Neutraceuticals, Inc.

March 21, 2006 08:00 ET

Sunwin International Neutraceuticals to Host a Series of Investor Presentations in the Coming Months

NEW YORK, NY and QUFU, CHINA -- (MARKET WIRE) -- March 21, 2006 -- Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN), a leader in the production and distribution of Chinese herbs, veterinary medicines and low calorie natural sweetener (Stevia) in China, announced it will host a series of investor conferences to communicate the Company's business strategy, acquisition developments, and growth potential to the investment community in the coming months. Members of the executive management team of Sunwin will be present at various events in Las Vegas, Chicago, New York, Miami, Los Angeles and San Francisco, in May 2006. The conferences are part of a campaign launched by the Company in the fourth quarter of 2005. Please visit investor sector at for a full itinerary.

Sunwin Investor Conference Itinerary

--  Investor luncheon -- Palm Beach, FL, March 24, 2006, 12pm - 2pm (EST),
    The Colony Hotel, 155 Hammon Avenue, Palm Beach, Florida 33480.
--  World Money Show, May 15-18, 2006.  SUWN will present in a workshop
    entitled "Investing in China" and will host a series of one-on-one meetings
    at Paris/Bally's Resort, 3655 Las Vegas Blvd. South, Las Vegas, Nevada
--  Global Chinese Financial Forum, June 10, 2006. SUWN will present in a
    workshop entitled "Investing in China" and will host a series of one-on-one
    meetings at Sheraton Gateway Hotel, 600 Airport Boulevard, San Francisco,
    CA 94010.
--  China Conference, June 27, 2007.  SUWN will present and will host a
    series of one-on-one meetings at the Luxe Hotel, 11461 Sunset Boulevard,
    Los Angeles, CA 90049.
All shareholders and prospective investors are welcome to attend. Please RSVP to Those interested in arranging one-to-one meetings with the management of Sunwin please coordinate with Jim Glickstein at 1-877-CHINA-57.

Laiwang Zhang, President and Chairman of Sunwin, stated, "Our Company is undergoing an exciting growth period. As part of our investor awareness campaign initiated in late 2005, we strive to communicate our message with the investment community."

Mr. Alan Stone, Managing Director of Alan Stone Company, LLC, stated, "In coordination with Sunwin we have arranged a comprehensive program to introduce SUWN and its representatives with a wide range of market professionals. Our goal at Alan Stone & Company, LLC is to present the exciting accomplishments and growth opportunities of Sunwin to the broader investment community. As demand for Chinese related securities remains strong; we believe that the planned events and activities will improve the Company's visibility on Wall Street, broaden its shareholder base, increase the stock's trading liquidity and enhance long-run shareholder value."

About Sunwin International Neutraceuticals, Inc.

Sunwin International Neutraceuticals, Inc. (OTC BB: SUWN) is engaged in the areas of essential traditional Chinese medicine, 100% organic herbal medicine, neutraceutical products, natural sweetener (Stevia), and veterinary medicines and feeds prepared from 100% organic herbal ingredients. As an industry leader in agricultural processing, Sunwin has built an integrated global firm with the sourcing and production capabilities to meet the needs of consumers throughout the world. Sunwin also makes such value-added products as specialty veterinary food ingredients and specialty feed ingredients. The Sunwin family works closely with consumers to provide a quality and a hybrid mix of agricultural products and services that meet growing demand. In 2002, Sunwin was recognized as one of the first 2,000 state-level companies that China authorized as the most important innovative high-tech pioneer businesses by the Chinese central government. In 2002, Sunwin was awarded as one of 2002 state-level biological product manufacturers in China. In 2003, Sunwin ranked as one of the top 50 companies of China Animal Related Health Care Product Pharmaceutical Industry. In 2003, Sunwin received award of Shandong Top-Ten Innovative, High-Tech Businesses by the Province Government of Shandong. For more info about Sunwin, please visit

Safe Harbor Statement

Certain of the statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance or achievements, and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may" or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements. Forward-looking statements involve risks and uncertainties, including those relating to the Company's ability to grow its business. Actual results may differ materially from the results predicted and reported results should not be considered as an indication of future performance. The potential risks and uncertainties include, among others, the Company's limited financial resources, domestic or global economic conditions -- especially those relating to China, activities of competitors and the presence of new or additional competition, and changes in Federal or State laws, restrictions and regulations on doing business in a foreign country, in particular China, and conditions of equity markets. More information about the potential factors that could affect the Company's business and financial results is included in the Company's filings, available via the United States Securities and Exchange Commission.

Contact Information